Encorafenib M17919
The add to cart button will appear once you select the values above
Specifications
| inquiry |
CAS Number:
1269440-17-6
Target:
HDAC
Molecular formula:
C22H27ClFN7O4S
Formula weight:
540,01
Purity:
>98% (HPLC)
Stability:
≥ 2 years
Product description:
LGX818 is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity.
Note:
Research use only, not for human use.
More info:
Email info@sobekbio.com
Orders:
Email orders@sobekbio.com